CNBX PHARMACEUTICALS INC. (CNBX)

Every figure this model derived for CNBX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-05-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2016-05-31
cash 9,487 CashAndCashEquivalentsAtCarryingValue 2026-05-31
current assets 12,795 AssetsCurrent 2026-05-31
current liabilities 2,672,509 LiabilitiesCurrent 2026-05-31
equity -2,659,714 StockholdersEquity 2026-05-31
interest expense 46,181 InterestExpenseDebt 2026-02-28
ocf -154,169 NetCashProvidedByUsedInOperatingActivities 2026-05-31
revenue 0 Revenues 2026-05-31
sbc 0 ShareBasedCompensation 2025-11-30

The ratios

The figures themselves rather than their scores — what somebody looking up CNBX on one particular measure came for.

RatioValue
current ratio0.0
current ratio reported0.0
growth cv2.76
interest cover-9.3

What to be careful about

What this model itself distrusts about CNBX's figures. Written by the derivation as it ran, not added afterwards.